NFIB Mediates BRN2 Driven Melanoma Cell Migration and Invasion Through Regulation of EZH2 and MITF

[1]  Alicia N. Schep,et al.  Nfib Promotes Metastasis through a Widespread Increase in Chromatin Accessibility , 2016, Cell.

[2]  Ji-Ying Song,et al.  Transcription Factor NFIB Is a Driver of Small Cell Lung Cancer Progression in Mice and Marks Metastatic Disease in Patients , 2016, Cell reports.

[3]  Farzana Ahmed,et al.  Imaging- and Flow Cytometry-based Analysis of Cell Position and the Cell Cycle in 3D Melanoma Spheroids. , 2015, Journal of visualized experiments : JoVE.

[4]  C. Wellbrock,et al.  Microphthalmia‐associated transcription factor in melanoma development and MAP‐kinase pathway targeted therapy , 2015, Pigment cell & melanoma research.

[5]  S. Aerts,et al.  Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state , 2015, Nature Communications.

[6]  R. Gronostajski,et al.  Nuclear factor one transcription factors: Divergent functions in developmental versus adult stem cell populations , 2015, Developmental dynamics : an official publication of the American Association of Anatomists.

[7]  R. Dummer,et al.  The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors , 2015, Nature Communications.

[8]  M. Czyz,et al.  MITF in melanoma: mechanisms behind its expression and activity , 2014, Cellular and Molecular Life Sciences.

[9]  G. Berx,et al.  Melanoma Cells Revive an Embryonic Transcriptional Network to Dictate Phenotypic Heterogeneity , 2014, Front. Oncol..

[10]  N. Haass,et al.  Real‐time cell cycle imaging during melanoma growth, invasion, and drug response , 2014, Pigment cell & melanoma research.

[11]  E. Sahai,et al.  Intravital imaging of SRF and Notch signalling identifies a key role for EZH2 in invasive melanoma cells , 2014, Oncogene.

[12]  C. Wellbrock,et al.  Heterogeneous Tumor Subpopulations Cooperate to Drive Invasion , 2014, Cell reports.

[13]  D. Friedmann-Morvinski,et al.  Dedifferentiation and reprogramming: origins of cancer stem cells , 2014, EMBO reports.

[14]  N. Wray,et al.  NFIB-Mediated Repression of the Epigenetic Factor Ezh2 Regulates Cortical Development , 2014, The Journal of Neuroscience.

[15]  Nikolas K. Haass,et al.  Modeling Melanoma In Vitro and In Vivo , 2013, Healthcare.

[16]  D. Schadendorf,et al.  MiR-101 inhibits melanoma cell invasion and proliferation by targeting MITF and EZH2. , 2013, Cancer letters.

[17]  Eugenia G. Giannopoulou,et al.  NFIB is a governor of epithelial–melanocyte stem cell behaviour in a shared niche , 2013, Nature.

[18]  K. Polyak,et al.  Intra-tumour heterogeneity: a looking glass for cancer? , 2012, Nature Reviews Cancer.

[19]  Wonshik Han,et al.  NFIB is a potential target for estrogen receptor‐negative breast cancers , 2011, Molecular oncology.

[20]  Levi Garraway,et al.  Nuclear factor I/B is an oncogene in small cell lung cancer. , 2011, Genes & development.

[21]  Gerald C. Chu,et al.  Proinvasion metastasis drivers in early-stage melanoma are oncogenes. , 2011, Cancer cell.

[22]  M. Herlyn,et al.  Inverse expression states of the BRN2 and MITF transcription factors in melanoma spheres and tumour xenografts regulate the NOTCH pathway , 2011, Oncogene.

[23]  Song Liu,et al.  Mesenchymal nuclear factor I B regulates cell proliferation and epithelial differentiation during lung maturation. , 2011, Developmental biology.

[24]  Elke Hacker,et al.  Melanoma cell invasiveness is regulated by miR‐211 suppression of the BRN2 transcription factor , 2011, Pigment cell & melanoma research.

[25]  Christian Mazza,et al.  Nuclear factor I revealed as family of promoter binding transcription activators , 2011, BMC Genomics.

[26]  T. Hornyak,et al.  EZH2-Dependent Suppression of a Cellular Senescence Phenotype in Melanoma Cells by Inhibition of p21/CDKN1A Expression , 2011, Molecular Cancer Research.

[27]  C. Goding,et al.  A picture of Mitf in melanoma immortality , 2011, Oncogene.

[28]  E. Sahai,et al.  Oncogenic BRAF induces melanoma cell invasion by downregulating the cGMP-specific phosphodiesterase PDE5A. , 2011, Cancer cell.

[29]  K. Hoek,et al.  Cancer stem cells versus phenotype‐switching in melanoma , 2010, Pigment cell & melanoma research.

[30]  S. Morrison,et al.  Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized. , 2010, Cancer cell.

[31]  D. Dembélé,et al.  Genome‐wide analysis of POU3F2/BRN2 promoter occupancy in human melanoma cells reveals Kitl as a novel regulated target gene , 2010, Pigment cell & melanoma research.

[32]  H. Horlings,et al.  Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck , 2009, Proceedings of the National Academy of Sciences.

[33]  E. Sahai,et al.  Intravital imaging reveals transient changes in pigment production and Brn2 expression during metastatic melanoma dissemination. , 2009, Cancer research.

[34]  M. Herlyn,et al.  Melanocytes: From Morphology to Application , 2009, Skin Pharmacology and Physiology.

[35]  R. Sturm,et al.  POU domain transcription factors: BRN2 as a regulator of melanocytic growth and tumourigenesis , 2008, Pigment cell & melanoma research.

[36]  P. Nuciforo,et al.  Brn-2 represses microphthalmia-associated transcription factor expression and marks a distinct subpopulation of microphthalmia-associated transcription factor-negative melanoma cells. , 2008, Cancer research.

[37]  Helen Pickersgill,et al.  Oncogenic BRAF Regulates Melanoma Proliferation through the Lineage Specific Factor MITF , 2008, PloS one.

[38]  J. Mesirov,et al.  Gene Expression Changes in an Animal Melanoma Model Correlate with Aggressiveness of Human Melanoma Metastases , 2008, Molecular Cancer Research.

[39]  R. Dummer,et al.  In vivo switching of human melanoma cells between proliferative and invasive states. , 2008, Cancer research.

[40]  M. Herlyn,et al.  In vitro three-dimensional tumor microenvironment models for anticancer drug discovery , 2008, Expert opinion on drug discovery.

[41]  Jane Goodall,et al.  Mitf regulation of Dia1 controls melanoma proliferation and invasiveness. , 2006, Genes & development.

[42]  D. Fisher,et al.  MITF: master regulator of melanocyte development and melanoma oncogene. , 2006, Trends in molecular medicine.

[43]  O. Halvorsen,et al.  EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[44]  D. Elder,et al.  A tumorigenic subpopulation with stem cell properties in melanomas. , 2005, Cancer research.

[45]  R. Sturm,et al.  Co-expression of SOX9 and SOX10 during melanocytic differentiation in vitro. , 2005, Experimental cell research.

[46]  L. Richards,et al.  The Transcription Factor Gene Nfib Is Essential for both Lung Maturation and Brain Development , 2005, Molecular and Cellular Biology.

[47]  M. Herlyn,et al.  Human melanoblasts in culture: expression of BRN2 and synergistic regulation by fibroblast growth factor-2, stem cell factor, and endothelin-3. , 2003, The Journal of investigative dermatology.

[48]  A. E. Sippel,et al.  Nuclear factor I-B (Nfib) deficient mice have severe lung hypoplasia , 2002, Mechanisms of Development.

[49]  I. Weissman,et al.  Stem cells, cancer, and cancer stem cells , 2001, Nature.

[50]  J. Cheville,et al.  Dedifferentiation in the metastatic progression of prostate carcinoma , 1999, Cancer.

[51]  P. Nowell.  The clonal evolution of tumor cell populations. , 1976, Science.

[52]  Loredana Spoerri,et al.  Real-Time Cell Cycle Imaging in a 3D Cell Culture Model of Melanoma. , 2017, Methods in molecular biology.

[53]  윤호주.  전사인자(transcription factor)와 기관지천식 , 1999 .

[54]  S. Sell,et al.  Environmental Health Perspectives 101(Suppl 5): 15-26 (1993) Cellular Origin of Cancer: Dedifferentiation or Stem Cell Maturation , 2022 .